News

Long-lasting HIV prevention shot headed toward approval
FA new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month.
The Lancet2d
Papua New Guinea's Village Health Attendants
Papua New Guinea's community volunteers provide essential services and health promotion, but the absence of financial support ...
The Lancet9d
Seeking an inclusive and just way to simplify the global health architecture
The 25-year-old joint commitment among established providers of official development assistance (ODA) to invest in efforts ...
RFK Jr. may stop government scientists from publishing in top journals
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he may no longer allow government ...
CNN-News181mon
HIV Cases Rising Among 50+ Age Group, Says Alarming Lancet Report
The study, published in The Lancet Healthy Longevity journal, reveals that HIV prevalence among older adults now surpasses that of younger individuals. Dr. Louiser Olubayo of the Sydney Brenner ...
app.com1mon
Activists brave the rain to raise money for HIV/AIDS services despite signs of uncertainty
Globally, HIV/AIDS-related deaths stood at 2.1 million ... according to the medical journal The Lancet. The number of cases and deaths represents a stunning drop over the past four decades.
CBS News2mon
Proposed foreign aid cuts could lead to millions of HIV deaths, study estimates
Published Wednesday in The Lancet HIV journal, the modeling study estimates that by 2030, there could be between 4.4 million to 10.8 million additional new HIV infections in low- and middle-income ...
EurekAlert!2mon
THE LANCET HIV: Proposed cuts to foreign aid could result in millions of HIV deaths and soaring rates of global HIV infections, new modelling study estimates
A new modelling study published in The Lancet HIV journal highlights the alarming potential impact of significant reductions in international funding for HIV prevention and treatment programmes.
Healio2mon
Gilead encouraged by data on once-yearly lenacapavir for HIV prevention
SAN FRANCISCO — New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as ... results simultaneously in The Lancet. A phase 1 trial found that ...
The New Indian Express2mon
Yearly HIV prevention injection 'Lenacapavir' shows promise in clinical trial
A yearly injection to protect against HIV is safe and shows promise as a prevention method with long-lasting effects, according to the results of a clinical trial published in The Lancet journal.
Morningstar2mon
First Clinical Data for Gilead’s Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet
First Clinical Data for Gilead’s Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet – Phase 1 Data Indicate Potential for Use of Once ...
The New England Journal of Medicine6mon
Long-Acting HIV Medicines and the Pandemic Inequality Cycle — Rethinking Access
The world may look back on 2024 as a pivotal time in the fight against AIDS — the start of a revolution in the global biomedical response to HIV using long-acting antiretroviral medicines.